3 min read
Climbing Mountains and Fighting Cancer – Fred Hutch Style
Editor’s Note: This is the second in a two-part blog series that takes us along with Rondo Therapeutics co-founder and...
3 min read
A Literal “Peak Experience” for Cancer Research
Editor’s Note: This is the first in a multi-part blog series that takes us along with Rondo Therapeutics co-founder and...
2 min read
John Kenney presents Cellestive discovery platform at 2022 AET Conference
Once again, Antibody Solutions was proud to participate as an event sponsor in the annual Antibody Engineering and...
1 min read
PEGS 2023
Antibody Solutions will be attending PEGS 2023, to be held May 15-19 in Boston, MA.
PEGS: The Essential Protein...
1 min read
AET 2022
Antibody Solutions will be attending AET 2022, to be held December 4-8 in San Diego, CA.
AET: The Antibody Engineering...
13 min read
Taking Aim with Antibody-Drug Conjugates
In 1902, the French filmmaker George Mèliés fascinated audiences with his film, Le Voyage dans la Lune (A Trip to the...
1 min read
PEGS 2022
Antibody Solutions will be attending PEGS 2022, to be held May 2-6 in Boston, MA.
PEGS: The Essential Protein...
3 min read
Looking Back on Omicron: Checking our predictions against recent reports
When the Omicron variant of SARS-CoV-2 was first identified, we applied our molecular modeling methods to assess how...
7 min read
Modeling the Impact of SARS-CoV-2 Omicron Variant Mutations
On November 24, 2021, South Africa reported the identification of a new SARS-CoV-2 variant, B.1.1.529, to the World...
5 min read
The Delta Variant Furin Domain Mutation Favors Greater Infectivity
The Delta variant has quickly become the predominant strain of SARS-CoV-2. Based on molecular modeling studies,...
6 min read
Functional Assays: Narrowing the Field from Binders to Therapeutic Candidates
Candidate ID: How to go from hits to lead candidates
We tend to think of antibodies as being defined by their...
1 min read
Original Research: Targeting Three Spike Protein Domains Regulating SARS-CoV-2 Infectivity
Like our research colleagues across the entire global scientific community, our team here at Antibody Solutions...
4 min read
Peptides: The Less-is-More Strategy for Success
A strategic approach to peptide design yields success
When deciding which antigens to use for an antibody discovery...
7 min read
Animals are Still Vital for Antibody Discovery
If the last year has taught us anything, it’s that major biological threats can emerge seemingly out of nowhere,...
4 min read
Getting your antigen to stand out in the crowd
Here at Antibody Solutions, we believe that starting with the best possible input will yield the best possible output....
Filter by Keyword
- Insights (32)
- COVID-19 (14)
- Covid (14)
- SARS-CoV-2 (14)
- Events (12)
- Molecuar Modeling (9)
- News (9)
- Transgenic Animals (5)
- antibody discovery (4)
- Therapeutic Targets (3)
- 25th Anniversary (2)
- Omicron (2)
- therapeutic monoclonal antibodies (2)
- ADC (1)
- Antibody-Drug Conjugate (1)
- CAR-T (1)
- Cell therapy (1)
- Functional Assays (1)
- Harbour (1)
- Hybridoma (1)
- IgG purification (1)
- Lambda Mouse (1)
- MAbExpress (1)
- Monoclonal (1)
- OmniRat (1)
- antigen (1)
- cell fusion (1)
- igG (1)
- immunoassays (1)
- immunogens (1)
- lambda light chain (1)
- mRNA (1)
- peptides (1)
- syngeneic (1)
- target analysis (1)
- transgenic H2L2 mice (1)
- women in bio (1)